- Revvity to Present at Goldman Sachs Global Healthcare Conference
- Revvity Announces Financial Results for the First Quarter of 2024
- Revvity Board Declares Quarterly Dividend
- Revvity to Present at BofA Securities 2024 Health Care Conference
- Revvity Unveils a New Era of Automated Tuberculosis Testing
- Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
- Revvity To Hold Earnings Call on Monday, April 29, 2024
- Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
- Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
More ▼
Key statistics
On Friday, Revvity Inc (RVTY:NYQ) closed at 110.92, -15.94% below its 52-week high of 131.96, set on Jul 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 110.30 |
---|---|
High | 111.05 |
Low | 109.60 |
Bid | 108.56 |
Offer | 113.34 |
Previous close | 111.02 |
Average volume | 951.03k |
---|---|
Shares outstanding | 123.39m |
Free float | 123.03m |
P/E (TTM) | 74.40 |
Market cap | 13.56bn USD |
EPS (TTM) | 1.48 USD |
Annual div (ADY) | 0.28 USD |
---|---|
Annual div yield (ADY) | 0.25% |
Div ex-date | Apr 18 2024 |
Div pay-date | May 10 2024 |
Next div ex-date | Jul 19 2024 |
Next div pay-date | Aug 09 2024 |
Data delayed at least 15 minutes, as of Jun 07 2024 21:10 BST.
More ▼